D. Sandre-giovannoli and A. , Lamin a truncation in Hutchinson-Gilford progeria, Science, vol.300, 2003.

M. Eriksson, Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome, Nature, vol.423, pp.293-298, 2003.

, SciEntific REPORtS |, vol.8, 2018.

P. Cau, Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective, Seminars in cell & developmental biology, vol.29, pp.125-147, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01646524

M. A. Merideth, Phenotype and course of Hutchinson-Gilford progeria syndrome, The New England journal of medicine, vol.358, pp.592-604, 2008.

J. I. Toth, Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes, Proceedings of the National Academy of Sciences of the United States of America, vol.102, pp.12873-12878, 2005.

L. B. Gordon, Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome, Proceedings of the National Academy of Sciences of the United States of America, vol.109, pp.16666-16671, 2012.

L. B. Gordon, Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome, Circulation, vol.130, pp.27-34, 2014.

I. Varela, Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging, Nature medicine, vol.14, pp.767-772, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00376425

F. G. Osorio, Splicing-directed therapy in a new mouse model of human accelerated aging, Science translational medicine, vol.3, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02193325

K. Cao, Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells, Science translational medicine, vol.3, 2011.

C. Pellegrini, All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype, Oncotarget, 2015.

N. Kubben, K. R. Brimacombe, M. Donegan, Z. Li, and T. Misteli, A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds, 2015.

A. Lo-cicero, A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells, Scientific reports, vol.6, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01469065

A. L. Egesipe, Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells. NPJ aging and mechanisms of disease 2, 16026, 2016.

K. Harhouri, MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation, EMBO molecular medicine, vol.9, pp.1294-1313, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01741719

D. W. Fawcett, On the occurrence of a fibrous lamina on the inner aspect of the nuclear envelope in certain cells of vertebrates, The American journal of anatomy, vol.119, pp.129-145, 1966.

R. D. Goldman, Y. Gruenbaum, R. D. Moir, D. K. Shumaker, and T. P. Spann, Nuclear lamins: building blocks of nuclear architecture, Genes & development, vol.16, pp.533-547, 2002.

K. Takahashi, K. Okita, M. Nakagawa, and S. Yamanaka, Induction of pluripotent stem cells from fibroblast cultures, Nature protocols, vol.2, pp.3081-3089, 2007.

Y. Maury, M. Gauthier, M. Peschanski, and C. Martinat, Human pluripotent stem cells for disease modelling and drug screening, BioEssays: news and reviews in molecular, cellular and developmental biology, vol.34, pp.61-71, 2012.

G. H. Liu, Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome, Nature, vol.472, pp.221-225, 2011.

J. Zhang, A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects, Cell stem cell, vol.8, pp.31-45, 2011.

X. Nissan, Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neuralspecific miR-9 microRNA, Cell reports, vol.2, pp.1-9, 2012.

Z. M. Xiong, C. Ladana, D. Wu, and K. Cao, An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells, Aging, vol.5, pp.288-303, 2013.

D. Fang, Defining the conditions for the generation of melanocytes from human embryonic stem cells, Stem cells, vol.24, pp.1668-1677, 2006.

X. Nissan, Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis, Proceedings of the National Academy of Sciences of the United States of America, vol.108, pp.14861-14866, 2011.

J. Allouche, In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells, Proceedings of the National Academy of Sciences of the United States of America, vol.112, pp.9034-9039, 2015.

K. Gledhill, Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells, PloS one, vol.10, 2015.

Y. Mica, G. Lee, S. M. Chambers, M. J. Tomishima, and L. Studer, Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs, Cell reports, vol.3, pp.1140-1152, 2013.

L. B. Gordon, F. G. Rothman, C. Lopez-otin, and T. Misteli, Progeria: a paradigm for translational medicine, Cell, vol.156, pp.400-407, 2014.

H. Zhang, Z. M. Xiong, and K. Cao, Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1, Proceedings of the National Academy of Sciences of the United States of America, vol.111, pp.2261-2270, 2014.

L. Atchison, H. Zhang, K. Cao, and G. A. Truskey, A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells, Scientific reports, vol.7, 2017.

S. Blondel, Induced pluripotent stem cells reveal functional differences between drugs currently investigated in patients with hutchinson-gilford progeria syndrome, Stem cells translational medicine, vol.3, pp.510-519, 2014.

C. R. Burtner and B. K. Kennedy, Progeria syndromes and ageing: what is the connection? Nature reviews, Molecular cell biology, vol.11, pp.567-578, 2010.

C. Lopez-otin, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, The hallmarks of aging, Cell, vol.153, pp.1194-1217, 2013.

S. Rodriguez, F. Coppede, H. Sagelius, and M. Eriksson, Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging, European journal of human genetics: EJHG, vol.17, pp.928-937, 2009.

P. Scaffidi and T. Misteli, Lamin A-dependent nuclear defects in human aging, Science, vol.312, pp.1059-1063, 2006.

D. Mcclintock, The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin, PloS one, vol.2, 1269.

M. Olive, Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arteriosclerosis, thrombosis, and vascular biology, vol.30, pp.2301-2309, 2010.

D. Mcclintock, L. B. Gordon, and K. Djabali, Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.2154-2159, 2006.

E. K. Benson, S. W. Lee, and S. A. Aaronson, Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence, Journal of cell science, vol.123, pp.2605-2612, 2010.

P. R. Musich and Y. Zou, Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A, Aging, vol.1, pp.28-37, 2009.

S. A. Richards, J. Muter, P. Ritchie, G. Lattanzi, and C. J. Hutchison, The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine, Human molecular genetics, vol.20, pp.3997-4004, 2011.

W. Montagna and K. Carlisle, Structural changes in ageing skin, The British journal of dermatology, vol.122, pp.61-70, 1990.

J. J. Nordlund, The lives of pigment cells, Dermatologic clinics, vol.4, pp.407-418, 1986.

M. M. Haddad, W. Xu, and E. E. Medrano, Aging in epidermal melanocytes: cell cycle genes and melanins. The journal of investigative dermatology, Symposium proceedings, vol.3, pp.36-40, 1998.

K. Takahashi, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, vol.131, pp.861-872, 2007.

G. Raposo, D. Tenza, D. M. Murphy, J. F. Berson, and M. S. Marks, Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells, The Journal of cell biology, vol.152, pp.809-824, 2001.